| DRUGS,HUMAN4501429003 | Manitoba Health, Seniors & Long Term Care | 55 000 $ | 10 juin 2026 |
| DRUGS,HUMAN4501385023 | Manitoba Health, Seniors & Long Term Care | 49 500 $ | 18 juin 2025 |
| Immunoglobuline anti-rabiqueCW2386067 | Department of Public Works and Government Services (PSPC) | 396,7 k $ | 20 févr. 2025 |
| DRUGS,HUMAN4501350959 | Manitoba Health, Seniors & Long Term Care | 36 000 $ | 18 sept. 2024 |
| IMMUNOGLOBULINE ANTI-HÉPATITE B HUMAINE (POST-EXPOSITION)202304AO-020 | Héma-Québec | 1,2 M $ | 31 janv. 2024 |
| DRUGS,HUMAN4501304046 | Manitoba Health, Seniors & Long Term Care | 48 334,41 $ | 24 juill. 2023 |
| DRUGS,HUMAN4501266393 | Manitoba Health | 35 000 $ | 7 sept. 2022 |
| DRUGS,HUMAN4501220955 | Manitoba Health and Seniors Care | 32 427,74 $ | 15 juill. 2021 |
| DRUGS,HUMAN4501180778 | Manitoba Health, Seniors and Active Living | 36 593,32 $ | 20 juill. 2020 |
| Modif 009 - Immunoglobuline antirabique - Grifols Canada Ltd.E60PH-20RIGG/002/PH | Department of Public Works and Government Services (PSPC) | 11,1 M $ | 13 févr. 2020 |
| Modif 008 - Immunoglobuline antirabique - Grifols Canada Ltd.E60PH-20RIGG/002/PH | Department of Public Works and Government Services (PSPC) | 11,1 M $ | 13 févr. 2020 |
| Modif 007 - Immunoglobuline antirabique - Grifols Canada Ltd.E60PH-20RIGG/002/PH | Department of Public Works and Government Services (PSPC) | 11,1 M $ | 13 févr. 2020 |
| DRUGS,HUMAN4501088328 | Manitoba Health, Seniors and Active Living | 22 112,28 $ | 11 juin 2018 |
| DRUGS,HUMAN4501033485 | Manitoba Health, Seniors and Active Living | 15 202,23 $ | 26 avr. 2017 |